Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer Patients
NCT03924609 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2019-04-23
Summary
The purpose of this study is to retrospectively collect and analyse the characteristics of breast cancer patients with bone metastasis, and compare the impact of intensive follow-up with standard post-operative surveillance on survival of Chinese breast cancer patients.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Intensive screening / routine screening
Recommendation and results of bone imaging such as bone scan or PET/CT, or bone CT /MR are collected.
Sponsors & Collaborators
-
Fudan University
collaborator OTHER -
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
collaborator OTHER -
Sun Yat-sen University
collaborator OTHER -
Harbin Medical University
collaborator OTHER -
Peking University People's Hospital
lead OTHER
Principal Investigators
-
Shu Wang, MD · Peking University People's Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-01
- Primary Completion
- 2019-03-31
- Completion
- 2019-03-31
Countries
- China
Study Locations
More Related Trials
-
Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET
NCT04992156 ·Status: COMPLETED
-
18F-FES PET/CT's Additional Clinical Value in ER+ BC
NCT04006626 ·Status: COMPLETED
-
[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors
NCT06455722 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET
NCT01224873 ·Status: UNKNOWN
-
Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.
NCT04080271 ·Status: COMPLETED
-
The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer
NCT01942759 ·Status: COMPLETED
-
Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET
NCT05914402 ·Status: RECRUITING ·Phase: NA
-
Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases
NCT04159376 ·Status: UNKNOWN ·Phase: NA
-
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
NCT00592462 ·Status: COMPLETED
-
Early Interim 18F-FDG-PET and 18F-FLT-PET for Predicting Treatment Response and Survival in Metastatic Breast Cancer
NCT04411966 ·Status: COMPLETED ·Phase: NA
-
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
NCT04316117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
NCT02969564 ·Status: COMPLETED
-
18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain
NCT01621906 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
NCT02839291 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET-CT Predicting Lymph Nodes Metastasis
NCT05970913 ·Status: ACTIVE_NOT_RECRUITING
-
The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer
NCT06915714 ·Status: COMPLETED
-
Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment
NCT04769050 ·Status: UNKNOWN
-
Al18F-HER2-BCH PET in Breast Patients Treated With ADC Therapy
NCT06909604 ·Status: RECRUITING ·Phase: NA
-
18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients
NCT06655545 ·Status: COMPLETED
-
CT Assessment of BMI in Endometrial Cancer Patients
NCT03962140 ·Status: COMPLETED
-
FDG PET-CT in Advanced Breast Cancer
NCT07173868 ·Status: RECRUITING
-
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949 ·Status: RECRUITING ·Phase: NA
-
Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI
NCT05744518 ·Status: UNKNOWN
-
Validation of Whole Body PET/CT Foundation Model
NCT07196995 ·Status: NOT_YET_RECRUITING